Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Resemblance between cataplexy during status cataplecticus, normal REM sleep

Resemblance between cataplexy during status cataplecticus, normal REM sleep

February 01, 2007

WESTCHESTER, Ill. — The first efforts to identify the neural structures and pathways underlying cataplexy during status cataplecticus in a narcoleptic patient, with the use of brain perfusion single photon emission computed tomography (SPECT), have led to the discovery that cataplexy during status cataplecticus, a case of prolonged cataplexy, partially resembles normal rapid eye movement (REM) sleep but without the other imaging characteristics of this state, according to a study published in the February 1st issue of the journal SLEEP.

The study, conducted by Dorothée Chabas, MD, PhD, of Université Pierre et Marie Curie-Paris, and Assistance Publique HÃ'pitaux de Paris, focused on a 68-year-old woman with hypocretin-deficient narcolepsy-cataplexy, who suffered status cataplecticus after having stopped clomipramine. The woman underwent a 99mTc-ethylcysteinate dimmer brain SPECT during an episode of cataplexy. This image was compared with her brain SPECT during an intervening asymptomatic period. Subtraction SPECT coregistered to magnetic resonance imaging (MRI)-determined anatomic areas differentially perfused during cataplexy and basal wakefulness state.




According to the results, the areas hyperactivated during cataplexy correspond on brain MRI with the cingular area, the left and right orbitofrontal cortex, the right temporal cortex and the right putamen, which are all activated during normal REM sleep. There was, however, no hyperactivation of the pons, amygdale or occipital cortex, other imaging characteristics of normal REM sleep.

"To my knowledge, this report is the first of imaging analysis comparing brain activation during a cataplectic episode with a nonsymptomatic state in the same subject," said Chabas. "Previous imaging studies have failed to show structural changes in the brain of narcoleptic patients, but functional changes could be demonstrated. The method used in this particular study analyzed functional features specifically related to the mechanisms of cataplexy. Picturing brain activity during cataplexy, a transient and unpredictable neurologic state, is challenging. It is, however, easier to study cataplexy during status cataplecticus."

The National Heart Lung and Blood Institute estimated that nearly three out of four people with narcolepsy also have cataplexy, a major symptom of narcolepsy, which is characterized by a sudden, bilateral loss of muscle tone (and possible fall) with preserved consciousness. It is usually triggered by emotions. Mild attacks of muscle weakness can cause:

- Head nodding
- Drooping eyelids
- Difficulty speaking
- Difficulty moving arms or hands or a weakened grip
- Buckling of the knees

Persons who think they might have a sleep disorder are discussed to discuss the problem with their primary care physician, who will refer them to a sleep specialist.

American Academy of Sleep Medicine



Related Cataplexy Current Events and Cataplexy News Articles Cataplexy Current Events and Cataplexy News RSS Cataplexy Current Events and Cataplexy News RSS
Narcolepsy is an autoimmune disorder, Stanford researcher says
Ten years ago, Stanford University School of Medicine scientist Emmanuel Mignot, MD, PhD, and his colleagues made headlines when they identified the culprit behind the sleep disorder narcolepsy.

Genetic study confirms the immune system's role in narcolepsy
Scientists funded by the National Institutes of Health have identified a gene associated with narcolepsy, a disorder that causes disabling daytime sleepiness, sleep attacks, irresistible bouts of sleep that can strike at any time, and disturbed sleep at night.

Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms
A study in the April 15 issue of the Journal of Clinical Sleep Medicine is the first to assess the effectiveness of treating sleep disorders in adults with a traumatic brain injury (TBI). Results indicate that treatment may result in the objective resolution of the sleep disorder without improvements in daytime sleepiness or neuropsychological function.

New study in the journal SLEEP finds a high prevalence of eating disorders in narcoleptics
The majority of patients with narcolepsy/cataplexy experience a number of symptoms of eating disorders, with an irresistible craving for food and binge eating as the most prominent features, according to a study published in the March 1 issue of the journal SLEEP.

Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin
Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition.

Fish get insomnia, eyes wide open, say Stanford sleep researchers
Scientists at the Stanford University School of Medicine have hooked a fish that suffers from insomnia in their quest to understand the genetics behind sleep disorders.

Lower metabolism, eating behavior possibly explain the cause of overweight in narcolepsy
A lower metabolism, as well as slight changes in eating behavior, could explain the positive energy balance leading to being overweight in narcolepsy.

Persons with narcolepsy with cataplexy have low levels of CSF hypocretin-1
Persons with narcolepsy with cataplexy have low levels of cerebrospinal fluid (CSF) hypocretin-1, a protein thought to help regulate sleep and wakefulness, according to a study published in the August 1st issue of the journal SLEEP.

A low expression of MX2 gene exists in the white blood cells of narcoleptics
The first report to identify the biological markers of narcolepsy using gene expression in white blood cells finds that the MX2 gene, which is relevant to the immune system, is significantly less expressed in narcoleptics compared with normal subjects.

UCLA Researchers Discover Link Between Parkinson's and Narcolepsy
Parkinson's disease is well-known for its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking. Less well known is that Parkinson's shares other symptoms with narcolepsy, a sleep disorder characterized by sudden and uncontrollable episodes of deep sleep, severe fatigue and general sleep disorder.
More Cataplexy Current Events and Cataplexy News Articles
Blazina Choir Under the Secrets of Hell [Explicit]

Blazina Choir Under the Secrets of Hell [Explicit]
Cataplexy (Primary Contributor)



  Look for cataplexy in diagnosing narcolepsy.(Clinical Rounds)(Disease/Disorder overview): An article from: Family Practice News
by Robert Finn (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on March 1, 2007. The length of the article is 746 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Look for cataplexy in diagnosing narcolepsy.(Clinical Rounds)(Disease/Disorder overview)
Author: Robert Finn
Publication: Family Practice News (Magazine/Journal)
Date: March 1, 2007
Publisher: Thomson Gale
Volume: 37 Issue: 5 Page: 50(1)

Article Type: Disease/Disorder overview

Distributed by Thomson...

Lunar Eclipse/Chaos to

Lunar Eclipse/Chaos to
by Cataplexy



... Lunar Eclipse, Chaos to the Ruin ... [Explicit]

... Lunar Eclipse, Chaos to the Ruin ... [Explicit]
Cataplexy (Primary Contributor)



  Sodium Oxybate Works for Cataplexy, but Has Abuse Potential.: An article from: Internal Medicine News
by Mitchel L. Zoler (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on July 15, 2001. The length of the article is 855 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Sodium Oxybate Works for Cataplexy, but Has Abuse Potential.
Author: Mitchel L. Zoler
Publication: Internal Medicine News (Magazine/Journal)
Date: July 15, 2001
Publisher: International Medical News Group
Volume: 34 Issue: 14 Page: 10

Article Type: Product/Service Evaluation

Distributed by Thomson...

Groan of Eternal Hate [Explicit]

Groan of Eternal Hate [Explicit]
Cataplexy (Primary Contributor)



  'Club Drug' approved by FDA for cataplexy in narcoleptic patients. (Prescribing Highly Restricted).: An article from: Clinical Psychiatry News
by Elizabeth Mechcatie (Author)

This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on October 1, 2002. The length of the article is 6346 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: 'Club Drug' approved by FDA for cataplexy in narcoleptic patients. (Prescribing Highly Restricted).
Author: Elizabeth Mechcatie
Publication: Clinical Psychiatry News (Magazine/Journal)
Date: October 1, 2002
Publisher: International Medical News Group
Volume: 30 Issue: 10 Page: 17(1)

Distributed by Thomson...

Graces of Infidel Blood [Explicit]

Graces of Infidel Blood [Explicit]
Cataplexy (Primary Contributor)



Hideous Path of Hate from the Abyss [Explicit]

Hideous Path of Hate from the Abyss [Explicit]
Cataplexy (Primary Contributor)



  FDA Approval of 'Club Drug' for Cataplexy Is Imminent.(sodium oxybate (Xyrem) therapy to be restricted): An article from: Clinical Psychiatry News
by Mitchel L. Zoler (Author)

This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on August 1, 2001. The length of the article is 865 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA Approval of 'Club Drug' for Cataplexy Is Imminent.(sodium oxybate (Xyrem) therapy to be restricted)
Author: Mitchel L. Zoler
Publication: Clinical Psychiatry News (Magazine/Journal)
Date: August 1, 2001
Publisher: International Medical News Group
Volume: 29 Issue: 8 Page: 17

Distributed by Thomson...

© 2009 BrightSurf.com